- Home
- XBIT vs NTRB Comparison
XBIT vs NTRB Comparison
Compare XBIT & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIT
- NTRB
- Stock Information
- Founded
- XBIT 2005
- NTRB 2016
- Country
- XBIT United States
- NTRB United States
- Employees
- XBIT N/A
- NTRB N/A
- Industry
- XBIT Pharmaceuticals and Biotechnology
- NTRB Industrial Specialties
- Sector
- XBIT Health Care
- NTRB Health Care
- Exchange
- XBIT Nasdaq
- NTRB Nasdaq
- Market Cap
- XBIT 82.3M
- NTRB 87.2M
- IPO Year
- XBIT 2015
- NTRB N/A
- Fundamental
- Price
- XBIT $2.62
- NTRB $7.62
- Analyst Decision
- XBIT
- NTRB Buy
- Analyst Count
- XBIT 0
- NTRB 1
- Target Price
- XBIT N/A
- NTRB $13.00
- AVG Volume (30 Days)
- XBIT 61.7K
- NTRB 32.7K
- Earning Date
- XBIT 11-12-2025
- NTRB 09-09-2025
- Dividend Yield
- XBIT N/A
- NTRB N/A
- EPS Growth
- XBIT N/A
- NTRB N/A
- EPS
- XBIT N/A
- NTRB N/A
- Revenue
- XBIT N/A
- NTRB $2,578,059.00
- Revenue This Year
- XBIT N/A
- NTRB $560.75
- Revenue Next Year
- XBIT N/A
- NTRB $588.39
- P/E Ratio
- XBIT N/A
- NTRB N/A
- Revenue Growth
- XBIT N/A
- NTRB 42.92
- 52 Week Low
- XBIT $2.50
- NTRB $2.98
- 52 Week High
- XBIT $8.32
- NTRB $9.42
- Technical
- Relative Strength Index (RSI)
- XBIT 37.18
- NTRB 64.09
- Support Level
- XBIT $2.62
- NTRB $6.82
- Resistance Level
- XBIT $2.72
- NTRB $7.94
- Average True Range (ATR)
- XBIT 0.12
- NTRB 0.43
- MACD
- XBIT -0.01
- NTRB 0.09
- Stochastic Oscillator
- XBIT 2.49
- NTRB 86.20
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.